Scarica l'app Stockscreener
1.31
0.76%
-0.01
Dopo l'orario di chiusura:
1.32
0.01
+0.76%
Pulmatrix Inc Borsa (PULM) Ultime notizie
If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan
FOMO Trade: Will Pulmatrix Inc benefit from current market trendsQuarterly Trade Review & Consistent Income Trade Recommendations - baoquankhu1.vn
FRA:2PU PB Ratio: 1.34 — 15% Above Median - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce $19 Million Merger to Advance Mitochondrial Therapies - Global Legal Chronicle
Pulmatrix shares dive as privately-held pharma company chooses to merge with Gyre Therapeutics instead - MSN
Ideas Watch: Is Pulmatrix Inc in a consolidation phaseQuarterly Trade Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Pulmatrix and Eos SENOLYTIX Announce $19M Merger to Advance AI-Driven Mitochondrial Therapies for Sarcopenia and Aging-Related Diseases 1 - minichart.com.sg
Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq - TipRanks
Pulmatrix to Merge With Eos SENOLYTIX; Raises $1M Preferred, Eos Secures Up to $18M - TradingView
Pulmatrix (PULM) plans reverse merger with Eos SENOLYTIX, legacy holders keep ~6% - Stock Titan
Haynes Boone Advises on Pulmatrix–Eos Merger and $19MM Financing - ABF Journal
Pulmatrix to acquire Eos SENOLYTIX in $19M anti-aging deal - Investing.com India
Pulmatrix and Eos SENOLYTIX Unite to Pioneer Anti-Aging Therapies Targeting Mitochondrial Health - Beijing Times
Deal Watch: Pulmatrix Finds New Merger Partner In Eos Senolytix - Citeline News & Insights
Eos SENOLYTIX, Inc. agreed to acquire Pulmatrix, Inc. in a reverse merger transaction. - MarketScreener
Aug Fed Impact: Is Pulmatrix Inc forming higher highs and higher lows2026 Market Mood & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Pulmatrix: Merger With Eos SENOLYTIX To Advance Mitochondrial Therapies - Pulse 2.0
Pulmatrix To Merge with Eos SENOLYTIX - citybiz
Pulmatrix (PULM) to Acquire Eos Senolytix in Strategic Merger - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PR Newswire
Pulmatrix, Inc. announced that it expects to receive $1 million in funding - MarketScreener
Buyout Rumor: Can Pulmatrix Inc grow without dilution2026 Closing Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Aug Catalysts: What are the analyst revisions for Vroom IncIs Pulmatrix Inc stock a good investment in YEARTrade Exit Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Risk Off: What is the earnings history of Pulmatrix IncWeekly Stock Report & Weekly High Conviction Ideas - baoquankhu1.vn
Why Pulmatrix Inc. stock is a value investor pickJuly 2025 Price Swings & Daily Growth Stock Investment Tips - Naître et grandir
Surprises Report: Will Pulmatrix Inc benefit from rising consumer demandShare Buyback & Capital Efficient Trade Techniques - baoquankhu1.vn
Pulmatrix, Inc. (PULM) Competitors - Meyka
PULM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmatrix Pursues New Reverse Merger After Cullgen Termination - The Globe and Mail
Pulmatrix merger with Cullgen terminated by Chinese firm - Investing.com
Behavioral Patterns of PULM and Institutional Flows - Stock Traders Daily
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Asianet Newsable
Pulmatrix and Cullgen Terminate Merger Agreement - Contract Pharma
Pulmatrix (PULM) Pursues New Merger Opportunities Post Agreement Termination - GuruFocus
Pulmatrix announces termination of prior planned merger and continues pursuit of alternative merger opportunities - marketscreener.com
Pulmatrix Announces Termination Of Prior Planned Merger And Continues Pursuit Of Alternative Merger Opportunities - TradingView
Pulmatrix-Cullgen Merger Agreement Terminated; No Fees Payable - TradingView
CSRC delays leave Pulmatrix merger dead, company hunts new deal - Stock Titan
Pulmatrix, Inc. SEC 10-K Report - TradingView
Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PULM: Revenue fell to nil in 2025 as the company pivots to merger and asset monetization strategies - TradingView
Pulmatrix (NASDAQ: PULM) cuts 2025 loss to $5.2M as Cullgen merger awaits approvals - Stock Titan
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PR Newswire
Pulmatrix | 10-K: FY2025 Annual Report - Moomoo
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results | PULM Stock News - Longbridge
PULM PE Ratio & Valuation, Is PULM Overvalued - Intellectia AI
Why Pulmatrix Inc. stock is in analyst buy zone2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
Update Report: Will Pulmatrix Inc benefit from seasonalityVolume Spike & Technical Buy Zone Confirmations - baoquankhu1.vn
(PULM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Earnings Report: What is the earnings history of Pulmatrix IncPortfolio Value Summary & AI Driven Price Forecasts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Share Price Crosses Below 50 Day Moving Average – What’s Next? - Defense World
Will Pulmatrix Inc. stock gain from strong economy2025 Macro Impact & Safe Swing Trade Setup Alerts - mfd.ru
Is Pulmatrix Inc. stock a buy before product launchesPortfolio Profit Report & AI Driven Stock Movement Reports - mfd.ru
Pulmatrix Announces Third Quarter 2024 Financial Results and Pro - GuruFocus
Is Pulmatrix Inc. stock a defensive play in 2025Short Setup & Technical Pattern Alert System - mfd.ru
Can Pulmatrix Inc. deliver alphaJuly 2025 Volume & Weekly Return Optimization Plans - mfd.ru
Will Pulmatrix Inc. benefit from rising consumer demandJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - mfd.ru
How (PULM) Movements Inform Risk Allocation Models - Stock Traders Daily
Profit Review: Will Pulmatrix Inc benefit from rising consumer demandPortfolio Value Report & Low Risk Entry Point Guides - baoquankhu1.vn
Will Pulmatrix Inc benefit from rising consumer demandPortfolio Value Report & Low Risk Entry Point Guides - baoquankhu1.vn
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):